
Nintevro Tablets 150 mg (Nintedanib Mesylate)
180.6mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.
Nintedanib esylate is a fibrillation progress inhibiting ingredient used in the treatment of pulmonary fibrosis.
MFDS ingredient code M285156
Nintedanib esylate is a drug that belongs to the class of tyrosine kinase inhibitors. It is mainly used to slow the progression of fibrosis in lung diseases such as idiopathic pulmonary fibrosis. This ingredient aims to regulate the abnormal fibrotic process in lung tissue.
Nintedanib esylate inhibits the proliferation and migration of fibroblasts by blocking the tyrosine kinase activity of several growth factor receptors. This helps prevent excessive fibrosis in lung tissue and slows down the deterioration of lung function.
Approved uses differ by product. Check each product's information for its actual use.
Unlike other antifibrotic agents, nintedanib esylate exhibits multi-tyrosine kinase inhibitory activity, simultaneously blocking various signaling pathways. As a result, it shows specialized efficacy in the treatment of pulmonary fibrosis, and its side effect profile differs somewhat.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
9 total

180.6mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

120.4mg
Tablet · Prescription medication
Youngjin Pharm Co., Ltd.

180.6mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

120.4mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

180.6mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.
120.4mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.
180.6mg
Tablet · Prescription medication
Hwanin Pharmaceutical Co., Ltd.

120.4mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.

180.6mg
Tablet · Prescription medication
Kolon Pharmaceutical Co., Ltd.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.